CyBio AG Adds to Top Management

Jena, (PresseBox) - The Supervisory Board of CyBio AG (Deutsche Börse: General Standard, ISIN-Number DE0005412308) appointed Thomas Moore as a member of the Company's Executive Management Board responsible for Sales and R&D effective September 1, 2009. The appointment of the 53 year old Thomas Moore, who has worked for the Company since its foundation in 1996, is meant to bundle and to further strengthen the responsibilities in these areas. CyBio will not be effected with additional costs due to the expansion of the management.

Thomas Moore, who has directed the Company OPALJENA, that has been traded as CyBio Instruments since 1999, as Executive Manager until 2002. From 1991 to 1996 he managed the R&D activities of JENOPTRON. Moore possesses broad experience in the fields of optics, optoelectronics, lab automation and liquid handling. Recently he managed the new life science department at CyBio AG, that will prospectively contribute to the Company's sales increase.

"The restructuring and the strengthening of the sales unit are important success factors for the further development of CyBio", says Jens Adomat, who has been interim Executive Board of the Company since August 18, 2009. "Major objectives will be to consistently continue the integration measures, to optimize existing processes in terms of cost reduction, and to realize synergy effects and sales opportunities. It is also necessary to force the R&D activities. With Thomas Moore we have an experienced manager on board, who knows the hts-pharmaceutical market and CyBio's customers very well. With this appointment we strengthen our business at a critical point."

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.